Loading…
Human cytomegalovirus protein pUL36: A dual cell death pathway inhibitor
Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of intrinsic, innate, and adaptive viral immune evasion. Here, we employed multiplexed tandem mass tag-based proteomics to characterize host proteins targeted for degradation late during HCMV infection. This approach revealed...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 2020-08, Vol.117 (31), p.18771-18779 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c443t-c8f89cce634e18fcf1e825d15ca8170e092bf6783053e00c59455a7ec44d9b83 |
---|---|
cites | cdi_FETCH-LOGICAL-c443t-c8f89cce634e18fcf1e825d15ca8170e092bf6783053e00c59455a7ec44d9b83 |
container_end_page | 18779 |
container_issue | 31 |
container_start_page | 18771 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 117 |
creator | Fletcher-Etherington, Alice Nobre, Luis Nightingale, Katie Antrobus, Robin Nichols, Jenna Davison, Andrew J. Stanton, Richard J. Weekes, Michael P. |
description | Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of intrinsic, innate, and adaptive viral immune evasion. Here, we employed multiplexed tandem mass tag-based proteomics to characterize host proteins targeted for degradation late during HCMV infection. This approach revealed that mixed lineage kinase domain-like protein (MLKL), a key terminal mediator of cellular necroptosis, was rapidly and persistently degraded by the minimally passaged HCMV strain Merlin but not the extensively passaged strain AD169. The strain Merlin viral inhibitor of apoptosis pUL36 was necessary and sufficient both to degrade MLKL and to inhibit necroptosis. Furthermore, mutation of pUL36 Cys131 abrogated MLKL degradation and restored necroptosis. As the same residue is also required for pUL36-mediated inhibition of apoptosis by preventing proteolytic activation of procaspase-8, we define pUL36 as a multifunctional inhibitor of both apoptotic and necroptotic cell death. |
doi_str_mv | 10.1073/pnas.2001887117 |
format | article |
fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7414183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>26935630</jstor_id><sourcerecordid>26935630</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-c8f89cce634e18fcf1e825d15ca8170e092bf6783053e00c59455a7ec44d9b83</originalsourceid><addsrcrecordid>eNpdkEtLAzEUhYMotj7WrpRCN25Gb16TZCNIUSsU3Og6pGmmTpmZjMmM0H9vSmt9rO7ifOdwz0HoAsMNBkFv28bEGwKApRQYiwM0xKBwljMFh2gIQEQmGWEDdBLjCgAUl3CMBpTkCgSwIRpP-9o0I7vufO2WpvKfZejjqA2-c2Uzat9mND9DR4Wpojvf3VP0-vjwOplms5en58n9LLOM0S6zspDKWpdT5rAsbIGdJHyBuTUSC3CgyLzIhaTAqQOwXDHOjXDJvVBzSU_R3Ta27ee1W1jXdMFUug1lbcJae1Pqv0pTvuul_9SCYYYlTQHXu4DgP3oXO12X0bqqMo3zfdSEES4Vo4QkdPwPXfk-NKldoigDQXKsEnW7pWzwMQZX7J_BoDf7683--mf_5Lj63WHPfw-egMstsIqdD3s9yZTnFOgXPBmJqQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2434072619</pqid></control><display><type>article</type><title>Human cytomegalovirus protein pUL36: A dual cell death pathway inhibitor</title><source>PMC (PubMed Central)</source><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>Fletcher-Etherington, Alice ; Nobre, Luis ; Nightingale, Katie ; Antrobus, Robin ; Nichols, Jenna ; Davison, Andrew J. ; Stanton, Richard J. ; Weekes, Michael P.</creator><creatorcontrib>Fletcher-Etherington, Alice ; Nobre, Luis ; Nightingale, Katie ; Antrobus, Robin ; Nichols, Jenna ; Davison, Andrew J. ; Stanton, Richard J. ; Weekes, Michael P.</creatorcontrib><description>Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of intrinsic, innate, and adaptive viral immune evasion. Here, we employed multiplexed tandem mass tag-based proteomics to characterize host proteins targeted for degradation late during HCMV infection. This approach revealed that mixed lineage kinase domain-like protein (MLKL), a key terminal mediator of cellular necroptosis, was rapidly and persistently degraded by the minimally passaged HCMV strain Merlin but not the extensively passaged strain AD169. The strain Merlin viral inhibitor of apoptosis pUL36 was necessary and sufficient both to degrade MLKL and to inhibit necroptosis. Furthermore, mutation of pUL36 Cys131 abrogated MLKL degradation and restored necroptosis. As the same residue is also required for pUL36-mediated inhibition of apoptosis by preventing proteolytic activation of procaspase-8, we define pUL36 as a multifunctional inhibitor of both apoptotic and necroptotic cell death.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.2001887117</identifier><identifier>PMID: 32690704</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Apoptosis ; Apoptosis - physiology ; Biological Sciences ; Cell death ; Cells, Cultured ; Cytomegalovirus ; Cytomegalovirus - chemistry ; Cytomegalovirus - metabolism ; Cytomegalovirus - pathogenicity ; Cytomegalovirus Infections - metabolism ; Cytomegalovirus Infections - virology ; Degradation ; Humans ; Kinases ; MAP kinase ; Mutation ; Necroptosis ; Necroptosis - physiology ; Protein Binding ; Proteins ; Proteolysis ; Proteomics ; Viral Proteins - metabolism</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2020-08, Vol.117 (31), p.18771-18779</ispartof><rights>Copyright © 2020 the Author(s). Published by PNAS.</rights><rights>Copyright National Academy of Sciences Aug 4, 2020</rights><rights>Copyright © 2020 the Author(s). Published by PNAS. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-c8f89cce634e18fcf1e825d15ca8170e092bf6783053e00c59455a7ec44d9b83</citedby><cites>FETCH-LOGICAL-c443t-c8f89cce634e18fcf1e825d15ca8170e092bf6783053e00c59455a7ec44d9b83</cites><orcidid>0000-0003-3196-5545 ; 0000-0003-0093-7170 ; 0000-0002-6799-1182 ; 0000-0002-4991-9128 ; 0000-0001-9958-4699 ; 0000-0001-7313-9247 ; 0000-0003-0467-8989</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/26935630$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/26935630$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791,58236,58469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32690704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fletcher-Etherington, Alice</creatorcontrib><creatorcontrib>Nobre, Luis</creatorcontrib><creatorcontrib>Nightingale, Katie</creatorcontrib><creatorcontrib>Antrobus, Robin</creatorcontrib><creatorcontrib>Nichols, Jenna</creatorcontrib><creatorcontrib>Davison, Andrew J.</creatorcontrib><creatorcontrib>Stanton, Richard J.</creatorcontrib><creatorcontrib>Weekes, Michael P.</creatorcontrib><title>Human cytomegalovirus protein pUL36: A dual cell death pathway inhibitor</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of intrinsic, innate, and adaptive viral immune evasion. Here, we employed multiplexed tandem mass tag-based proteomics to characterize host proteins targeted for degradation late during HCMV infection. This approach revealed that mixed lineage kinase domain-like protein (MLKL), a key terminal mediator of cellular necroptosis, was rapidly and persistently degraded by the minimally passaged HCMV strain Merlin but not the extensively passaged strain AD169. The strain Merlin viral inhibitor of apoptosis pUL36 was necessary and sufficient both to degrade MLKL and to inhibit necroptosis. Furthermore, mutation of pUL36 Cys131 abrogated MLKL degradation and restored necroptosis. As the same residue is also required for pUL36-mediated inhibition of apoptosis by preventing proteolytic activation of procaspase-8, we define pUL36 as a multifunctional inhibitor of both apoptotic and necroptotic cell death.</description><subject>Apoptosis</subject><subject>Apoptosis - physiology</subject><subject>Biological Sciences</subject><subject>Cell death</subject><subject>Cells, Cultured</subject><subject>Cytomegalovirus</subject><subject>Cytomegalovirus - chemistry</subject><subject>Cytomegalovirus - metabolism</subject><subject>Cytomegalovirus - pathogenicity</subject><subject>Cytomegalovirus Infections - metabolism</subject><subject>Cytomegalovirus Infections - virology</subject><subject>Degradation</subject><subject>Humans</subject><subject>Kinases</subject><subject>MAP kinase</subject><subject>Mutation</subject><subject>Necroptosis</subject><subject>Necroptosis - physiology</subject><subject>Protein Binding</subject><subject>Proteins</subject><subject>Proteolysis</subject><subject>Proteomics</subject><subject>Viral Proteins - metabolism</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpdkEtLAzEUhYMotj7WrpRCN25Gb16TZCNIUSsU3Og6pGmmTpmZjMmM0H9vSmt9rO7ifOdwz0HoAsMNBkFv28bEGwKApRQYiwM0xKBwljMFh2gIQEQmGWEDdBLjCgAUl3CMBpTkCgSwIRpP-9o0I7vufO2WpvKfZejjqA2-c2Uzat9mND9DR4Wpojvf3VP0-vjwOplms5en58n9LLOM0S6zspDKWpdT5rAsbIGdJHyBuTUSC3CgyLzIhaTAqQOwXDHOjXDJvVBzSU_R3Ta27ee1W1jXdMFUug1lbcJae1Pqv0pTvuul_9SCYYYlTQHXu4DgP3oXO12X0bqqMo3zfdSEES4Vo4QkdPwPXfk-NKldoigDQXKsEnW7pWzwMQZX7J_BoDf7683--mf_5Lj63WHPfw-egMstsIqdD3s9yZTnFOgXPBmJqQ</recordid><startdate>20200804</startdate><enddate>20200804</enddate><creator>Fletcher-Etherington, Alice</creator><creator>Nobre, Luis</creator><creator>Nightingale, Katie</creator><creator>Antrobus, Robin</creator><creator>Nichols, Jenna</creator><creator>Davison, Andrew J.</creator><creator>Stanton, Richard J.</creator><creator>Weekes, Michael P.</creator><general>National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3196-5545</orcidid><orcidid>https://orcid.org/0000-0003-0093-7170</orcidid><orcidid>https://orcid.org/0000-0002-6799-1182</orcidid><orcidid>https://orcid.org/0000-0002-4991-9128</orcidid><orcidid>https://orcid.org/0000-0001-9958-4699</orcidid><orcidid>https://orcid.org/0000-0001-7313-9247</orcidid><orcidid>https://orcid.org/0000-0003-0467-8989</orcidid></search><sort><creationdate>20200804</creationdate><title>Human cytomegalovirus protein pUL36</title><author>Fletcher-Etherington, Alice ; Nobre, Luis ; Nightingale, Katie ; Antrobus, Robin ; Nichols, Jenna ; Davison, Andrew J. ; Stanton, Richard J. ; Weekes, Michael P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-c8f89cce634e18fcf1e825d15ca8170e092bf6783053e00c59455a7ec44d9b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Apoptosis</topic><topic>Apoptosis - physiology</topic><topic>Biological Sciences</topic><topic>Cell death</topic><topic>Cells, Cultured</topic><topic>Cytomegalovirus</topic><topic>Cytomegalovirus - chemistry</topic><topic>Cytomegalovirus - metabolism</topic><topic>Cytomegalovirus - pathogenicity</topic><topic>Cytomegalovirus Infections - metabolism</topic><topic>Cytomegalovirus Infections - virology</topic><topic>Degradation</topic><topic>Humans</topic><topic>Kinases</topic><topic>MAP kinase</topic><topic>Mutation</topic><topic>Necroptosis</topic><topic>Necroptosis - physiology</topic><topic>Protein Binding</topic><topic>Proteins</topic><topic>Proteolysis</topic><topic>Proteomics</topic><topic>Viral Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fletcher-Etherington, Alice</creatorcontrib><creatorcontrib>Nobre, Luis</creatorcontrib><creatorcontrib>Nightingale, Katie</creatorcontrib><creatorcontrib>Antrobus, Robin</creatorcontrib><creatorcontrib>Nichols, Jenna</creatorcontrib><creatorcontrib>Davison, Andrew J.</creatorcontrib><creatorcontrib>Stanton, Richard J.</creatorcontrib><creatorcontrib>Weekes, Michael P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fletcher-Etherington, Alice</au><au>Nobre, Luis</au><au>Nightingale, Katie</au><au>Antrobus, Robin</au><au>Nichols, Jenna</au><au>Davison, Andrew J.</au><au>Stanton, Richard J.</au><au>Weekes, Michael P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human cytomegalovirus protein pUL36: A dual cell death pathway inhibitor</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2020-08-04</date><risdate>2020</risdate><volume>117</volume><issue>31</issue><spage>18771</spage><epage>18779</epage><pages>18771-18779</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of intrinsic, innate, and adaptive viral immune evasion. Here, we employed multiplexed tandem mass tag-based proteomics to characterize host proteins targeted for degradation late during HCMV infection. This approach revealed that mixed lineage kinase domain-like protein (MLKL), a key terminal mediator of cellular necroptosis, was rapidly and persistently degraded by the minimally passaged HCMV strain Merlin but not the extensively passaged strain AD169. The strain Merlin viral inhibitor of apoptosis pUL36 was necessary and sufficient both to degrade MLKL and to inhibit necroptosis. Furthermore, mutation of pUL36 Cys131 abrogated MLKL degradation and restored necroptosis. As the same residue is also required for pUL36-mediated inhibition of apoptosis by preventing proteolytic activation of procaspase-8, we define pUL36 as a multifunctional inhibitor of both apoptotic and necroptotic cell death.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>32690704</pmid><doi>10.1073/pnas.2001887117</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-3196-5545</orcidid><orcidid>https://orcid.org/0000-0003-0093-7170</orcidid><orcidid>https://orcid.org/0000-0002-6799-1182</orcidid><orcidid>https://orcid.org/0000-0002-4991-9128</orcidid><orcidid>https://orcid.org/0000-0001-9958-4699</orcidid><orcidid>https://orcid.org/0000-0001-7313-9247</orcidid><orcidid>https://orcid.org/0000-0003-0467-8989</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 2020-08, Vol.117 (31), p.18771-18779 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7414183 |
source | PMC (PubMed Central); JSTOR Archival Journals and Primary Sources Collection |
subjects | Apoptosis Apoptosis - physiology Biological Sciences Cell death Cells, Cultured Cytomegalovirus Cytomegalovirus - chemistry Cytomegalovirus - metabolism Cytomegalovirus - pathogenicity Cytomegalovirus Infections - metabolism Cytomegalovirus Infections - virology Degradation Humans Kinases MAP kinase Mutation Necroptosis Necroptosis - physiology Protein Binding Proteins Proteolysis Proteomics Viral Proteins - metabolism |
title | Human cytomegalovirus protein pUL36: A dual cell death pathway inhibitor |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T22%3A08%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20cytomegalovirus%20protein%20pUL36:%20A%20dual%20cell%20death%20pathway%20inhibitor&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Fletcher-Etherington,%20Alice&rft.date=2020-08-04&rft.volume=117&rft.issue=31&rft.spage=18771&rft.epage=18779&rft.pages=18771-18779&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.2001887117&rft_dat=%3Cjstor_pubme%3E26935630%3C/jstor_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-c8f89cce634e18fcf1e825d15ca8170e092bf6783053e00c59455a7ec44d9b83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2434072619&rft_id=info:pmid/32690704&rft_jstor_id=26935630&rfr_iscdi=true |